Cx31.1 acts as a tumour suppressor in non-small cell lung cancer (NSCLC) cell lines through inhibition of cell proliferation and metastasis

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 5, 2012, Pages 1047-1059

  Zhang, Deqiang ^a   Chen, Chengwen ^a   Li, Yuan ^a   Fu, Xuping ^a   Xie, Yi ^a   Li, Yao ^a   Huang, Yan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cell cycle; Cx31.1; Cyclin D3; EMT; Metastasis; Non small cell lung cancer

Indexed keywords

CCND3 PROTEIN, HUMAN; CYCLIN D3; CYTOKERATIN 18; GAP JUNCTION PROTEIN; GJB3 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; VIMENTIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL PROLIFERATION; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CONNEXINS; CYCLIN D3; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-18; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; TUMOR SUPPRESSOR PROTEINS; VIMENTIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84860323553     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01389.x     Document Type: Article

References (61)

1. Eyre TA, Ducluzeau F, Sneddon TP, et al. The HUGO gene nomenclature database, 2006 updates. Nucleic Acids Res. 2006; 34: D319-21.
2. Haefliger JA, Bruzzone R, Jenkins NA, et al. Four novel members of the connexin family of gap junction proteins. Molecular cloning, expression, and chromosome mapping. J Biol Chem. 1992; 267: 2057-64.
3. Goliger JA, Paul DL. Expression of gap junction proteins Cx26, Cx31. 1, Cx37, and Cx43 in developing and mature rat epidermis. Am J Anat. 1994; 200: 1-13.
4. Harris AL. Emerging issues of connexin channels: biophysics fills the gap. Quart Rev Biophys. 2002; 34: 325-472.
5. Loewenstein WR, Kanno Y. Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature. 1966; 209: 1248-9.
6. Mesnil M, Crespin S, Avanzo JL, et al. Defective gap junctional intercellular communication in the carcinogenic process. Biochim. Biophys. Acta (BBA)-Biomembr. 2005; 1719: 125-45.
7. Naus CC, Laird DW. Implications and challenges of connexin connections to cancer. Nat Rev Cancer. 10: 435-41.
8. Yamasaki H, Naus CCG. COMMENTARY: role of connexin genes in growth control. Carcinogenesis. 1996; 17: 1199-213.
9. Cronier L, Crespin S, Strale PO, et al. Gap junctions and cancer: new functions for an old story. Antioxidants Redox Signal. 2009; 11: 323-38.
10. Rae RS, Mehta PP, Chang CC, et al. Neoplastic phenotype of gap-junctional intercellular communication-deficient WB rat liver epithelial cells and its reversal by forced expression of connexin 32. Molec Carcinog. 1998; 22: 120-7.
11. King TJ, Lampe PD. The gap junction protein connexin32 is a mouse lung tumour suppressor. Cancer Res. 2004; 64: 7191-6.
12. Avanzo JL, Mesnil M, Hernandez-Blazquez FJ, et al. Increased susceptibility to urethane-induced lung tumours in mice with decreased expression of connexin43. Carcinogenesis. 2004; 25: 1973-82.
13. Loewenstein WR, Rose B. The cell-cell channel in the control of growth. Semin Cell Biol. 1992; 3: 59-79.
14. McLachlan E, Shao Q, Wang H, et al. Connexins act as tumour suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res. 2006; 66: 9886-94.
15. Jiang JX, Gu S. Gap junction-and hemichannel-independent actions of connexins. Biochim Biophys Acta (BBA)-Biomembr. 2005; 1711: 208-14.
16. Zhang YW, Kaneda M, Morita I. The gap junction-independent tumour-suppressing effect of connexin 43. J Biol Chem. 2003; 278: 44852-6.
17. Khair E, Abu H, Klaus W, et al. Connexin-43 upregulation in micrometastases and tumour vasculature and its role in tumour cell attachment to pulmonary endothelium. BMC Med. 2008; 6: 20.
18. Cina C, Maass K, Theis M, et al. Involvement of the cytoplasmic C-terminal domain of connexin43 in neuronal migration. J Neurosci. 2009; 29: 2009-21.
19. Cronier L, Crespin S, Strale P, et al. Gap junctions and cancer: new functions for an old story. Antioxidants Redox Signal. 2009; 11: 323-38.
20. Elias L, Wang D, Kriegstein A. Gap junction adhesion is necessary for radial migration in the neocortex. Nature. 2007; 448: 901-7.
21. Laird D. The gap junction proteome and its relationship to disease. Trends Cell Biol. 2010; 20: 92-101.
22. Sánchez-Alvarez R, Paìno T, Herrero-González S, et al. Tolbutamide reduces glioma cell proliferation by increasing connexin43, which promotes the up-regulation of p21 and p27 and subsequent changes in retinoblastoma phosphorylation. Glia. 2006; 54: 125-34.
23. Zhang ZQ, Hu Y, Wang BJ, et al. Effective asymmetry in gap junctional intercellular communication between populations of human normal lung fibroblasts and lung carcinoma cells. Carcinogenesis. 2004; 25: 473-82.
24. Lee J, Dedhar S, Kalluri R, et al. The epithelial mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006; 172: 973-81.
25. Al Moustafa A, Alaoui-Jamali M, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene. 2002; 21: 2634-40.
26. Budunova I, Carbajal S, Viaje A, et al. Connexin expression in epidermal cell lines from SENCAR mouse skin tumours. Molec Carcinog. 1996; 15: 190-201.
27. Huang R, Fan Y, Hossain M, et al. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res. 1998; 58: 5089-96.
28. Omori Y, Yamasaki H. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner. Int J Cancer. 1998; 78: 446-53.
29. Moorby C, Patel M. Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Exp Cell Res. 2001; 271: 238-48.
30. Qin H, Shao Q, Curtis H, et al. Retroviral delivery of connexin genes to human breast tumour cells inhibits in vivo tumour growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem. 2002; 277: 29132-8.
31. Lee H, Lee I, Seul K, et al. Growth inhibition by connexin26 expression in cultured rodent tumour cells. Molec Cells. 2002; 14: 136-42.
32. Jiang J, Gu S. Gap junction- and hemichannel-independent actions of connexins. Biochim Biophys Acta (BBA)- Biomembr. 2005; 1711: 208-14.
33. Gellhaus A, Dong X, Propson S, et al. Connexin43 Interacts with NOV. J Biol Chem. 2004; 279: 36931-42.
34. Fujimoto E, Sato H, Shirai S, et al. Inhibition of Src activity enhances the tumour-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells. Oncol Rep. 2006; 15: 1359-65.
35. Henzl M, Thalmann I, Larson J, et al. The cochlear F-box protein OCP1 associates with OCP2 and connexin 26. Hear Res. 2004; 191: 101-9.
36. Schubert A, Schubert W, Spray D, et al. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry. 2002; 41: 5754-64.
37. Sherr C. D-type cyclins. Trends Biochem Sci. 1995; 20: 187-90.
38. Ito Y, Takeda T, Wakasa K, et al. Expression and possible role of cyclin D3 in human pancreatic adenocarcinoma. Anticancer Res. 2001; 21: 1043-8.
39. Hedberg Y, Roos G, Ljungberg B, et al. Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters. Acta Oncol. 2002; 41: 175-81.
40. Pruneri G, Pignataro L, Valentini S, et al. Cyclin D3 immunoreactivity is an independent predictor of survival in laryngeal squamous cell carcinoma. Clin Cancer Res. 2005; 11: 242-8.
41. Rodriguez-Puebla M, Robles A, Johnson D, et al. Synchronized proliferation induced by 12-O-tetradecanoylphorbol-13-acetate treatment of mouse skin: an in vivo model for cell cycle regulation. Cell Growth Different: Molec Biol J Am Assoc Cancer Res. 1998; 9: 31-9.
42. Rojas P, Cadenas M, Lin P, et al. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis. Oncogene. 2006; 26: 1723-30.
43. Micalizzi DS, Ford HL. Epithelial-mesenchymal transition in development and cancer. Future Oncol. 2009; 5: 1129-43.
44. McLachlan E, Shao Q, Wang H, et al. Connexins act as tumour suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res. 2006; 66: 9886-94.
45. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, et al. Autoregulation of E-cadherin expression by cadherin-cadherin interactions. J Cell Biol. 2003; 163: 847-57.
46. Gilles C, Polette M, Mestdagt M, et al. Transactivation of vimentin by β-catenin in human breast cancer cells. Cancer Res. 2003; 63: 2658-64.
47. Yu W, Kamara H, Svoboda KKH. The role of twist during palate development. Develop Dynam. 2008; 237: 2716-25.
48. Martinez-Alvarez C, Blanco MJ, Perez R, et al. Snail family members and cell survival in physiological and pathological cleft palates. Develop Biol. 2004; 265: 207-18.
49. Peinado H, Quintanilla M, Cano A. Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines. J Biol Chem. 2003; 278: 21113-23.
50. Cano A, Pérez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000; 2: 76-83.
51. Batlle E, Sancho E, Francí C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2: 84-9.
52. Vesuna F, van Diest P, Chen JH, et al. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun. 2008; 367: 235-41.
53. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Molec Cell Biol. 2006; 7: 131-42.
54. Zhang Z, Zhang W, Wang N, et al. Suppression of tumourigenicity of human lung carcinoma cells after transfection with connexin43. Carcinogenesis. 1998; 19: 1889-94.
55. Jinn Y, Ichioka M, Marumo F. Expression of connexin32 and connexin43 gap junction proteins and E-cadherin in human lung cancer. Cancer Lett. 1998; 127: 161-9.
56. Chen J, Cheng Y, Chou M, et al. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer. Clin Cancer Res. 2003; 9: 4200-4.
57. Terzaghi-Howe M, Chang G, Popp D. Emergence of undifferentiated rat tracheal cell carcinomas, but not squamous cell carcinomas, is associated with a loss of expression of E-cadherin and of gap junction communication. Carcinogenesis. 1997; 18: 2043-50.
58. Yano T, Yamasaki H. Regulation of cellular invasion and matrix metalloproteinase activity in HepG2 cell by connexin 26 transfection. Molec Carcinog. 2001; 31: 101-9.
59. Xu H, Li Q, Zhang Y, et al. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem Cytobiol. 2008; 46: 315-21.
60. Kostin S, Hein S, Bauer E, et al. Spatiotemporal development and distribution of intercellular junctions in adult rat cardiomyocytes in culture. Circ Res. 1999; 85: 154-67.
61. Thiery JP, Acloque H, Huang RYJ, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139: 871-90.